Epidemic Group Invests $34 Mln in Potential Vaccine Printer Tech Epidemic Group Invests $34 Mln in Potential Vaccine Printer Tech

A coalition seeking to get ahead of the next pandemic has agreed a $34 million deal with German biotech CureVac to develop vaccine"printing" technology that aims to rapidly produce shots against multiple diseases.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Public Health & Prevention News Source Type: news